Suppr超能文献

针对次要组织相容性抗原HA-1H的T细胞受体样抗体及嵌合抗原受体T细胞(CAR-T细胞)的构建与分子特征分析

Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.

作者信息

Inaguma Y, Akahori Y, Murayama Y, Shiraishi K, Tsuzuki-Iba S, Endoh A, Tsujikawa J, Demachi-Okamura A, Hiramatsu K, Saji H, Yamamoto Y, Yamamoto N, Nishimura Y, Takahashi T, Kuzushima K, Emi N, Akatsuka Y

机构信息

Department of Hematology, School of Medicine, Fujita Health University, Toyoake, Japan.

Division of Antibody Project, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.

出版信息

Gene Ther. 2014 Jun;21(6):575-84. doi: 10.1038/gt.2014.30. Epub 2014 Apr 3.

Abstract

The genetic transfer of T-cell receptors (TCRs) directed toward target antigens into T lymphocytes has been used to generate antitumor T cells efficiently without the need for the in vitro induction and expansion of T cells with cognate specificity. Alternatively, T cells have been gene-modified with a TCR-like antibody or chimeric antigen receptor (CAR). We show that immunization of HLA-A2 transgenic mice with tetramerized recombinant HLA-A2 incorporating HA-1 H minor histocompatibility antigen (mHag) peptides and β2-microglobulin (HA-1 H/HLA-A2) generate highly specific antibodies. One single-chain variable region moiety (scFv) antibody, #131, demonstrated high affinity (KD=14.9 nM) for the HA-1 H/HLA-A2 complex. Primary human T cells transduced with #131 scFV coupled to CD28 transmembrane and CD3ζ domains were stained with HA-1 H/HLA-A2 tetramers slightly more intensely than a cytotoxic T lymphocyte (CTL) clone specific for endogenously HLA-A2- and HA-1 H-positive cells. Although #131 scFv CAR-T cells required >100-fold higher antigen density to exert cytotoxicity compared with the cognate CTL clone, they could produce inflammatory cytokines against cells expressing HLA-A2 and HA-1 H transgenes. These data implicate that T cells with high-affinity antigen receptors reduce the ability to lyse targets with low-density peptide/MHC complexes (~100 per cell), while they could respond at cytokine production level.

摘要

将针对靶抗原的T细胞受体(TCR)基因转移到T淋巴细胞中,已被用于高效生成抗肿瘤T细胞,而无需在体外诱导和扩增具有同源特异性的T细胞。另外,也已用类TCR抗体或嵌合抗原受体(CAR)对T细胞进行基因改造。我们发现,用掺入HA-1 H次要组织相容性抗原(mHag)肽和β2-微球蛋白的四聚体重组HLA-A2(HA-1 H/HLA-A2)免疫HLA-A2转基因小鼠可产生高度特异性抗体。一种单链可变区部分(scFv)抗体#131对HA-1 H/HLA-A2复合物表现出高亲和力(KD=14.9 nM)。用与CD28跨膜结构域和CD3ζ结构域偶联的#131 scFV转导的原代人T细胞,与针对内源性HLA-A2和HA-1 H阳性细胞的细胞毒性T淋巴细胞(CTL)克隆相比,用HA-1 H/HLA-A2四聚体染色时强度略高。尽管与同源CTL克隆相比,#131 scFv CAR-T细胞发挥细胞毒性所需的抗原密度要高100倍以上,但它们可针对表达HLA-A2和HA-1 H转基因的细胞产生炎性细胞因子。这些数据表明,具有高亲和力抗原受体的T细胞虽然能够在细胞因子产生水平做出反应,但却降低了裂解低密度肽/MHC复合物(约每个细胞100个)靶标的能力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验